alzheimer's disease, Ozempic and Type 2 Diabetes

Ozempic May Be Linked to Lower Risk of Alzheimer’s in People with Type 2 Diabetes
According to a recent study, certain classes of weight loss drugs — including Ozempic — may have positive effects on the brain and patients with type 2 diabetes.
Ozempic may significantly lower the risk of Alzheimer’s disease — here’s how
Nearly 7 million Americans 65 and older are living with Alzheimer’s disease, which gradually destroys memory and thinking skills and the ability to perform daily tasks.
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer's diagnosis in diabetes patients.
Active ingredient in Ozempic, Wegovy may reduce risk of Alzheimer's disease: Study
Semaglutide, the active ingredient found in Ozempic and Wegovy, may reduce the risk of Alzheimer’s disease, a new study published Thursday morning finds.
Ozempic, Wegovy might lower Alzheimer's risk in Type 2 diabetics
People with Type 2 diabetes taking semaglutide appeared to have a significantly lower risk of developing Alzheimer's compared to patients taking seven other diabetes drugs, researchers reported.
Ozempic, Wegovy Might Help Lower Alzheimer's Risk in People With Diabetes
By Dennis Thompson HealthDay Reporter THURSDAY, Oct. 24, 2024 (HealthDay News) -- Add Alzheimer’s disease to the list of conditions that might benefit from the revolutionary diabetes drug Ozempic, a new study says.
Novo’s Ozempic Linked to Reduced Alzheimer’s Diagnoses
Patients taking Novo Nordisk A/S’s Ozempic were at significantly reduced risk of being diagnosed with Alzheimer’s, according to new research that adds to the evidence surrounding the drug’s effects in diseases beyond type 2 diabetes and obesity.
Popular Weight Loss Drugs Ozempic, Wegovy May Lower Alzheimer's Disease Risk
Type-2 diabetes patients taking the active ingredient in the drugs, semaglutide, "had a significantly lower risk" of developing the disease, the study found
Medline couple donates $25 million to Northwestern to create new center focused on Alzheimer’s
New artificial intelligence tools and analysis methods will be created through the center, to help neuroscientists study the genes and cell types affected by Alzheimer’s disease.
New Upstate MRI machine latest in SC efforts to boost Alzheimer’s, dementia research
South Carolina colleges continue their efforts to improve the detention and treatment of Alzheimer’s disease and dementia in ...
New Alzheimer’s research reveals ‘quiet’ phase of the disease, before symptoms appear
New details have emerged into how Alzheimer’s disease affects the brain. Researchers have identified cellular changes in the ...
Crain's Chicago Business41m
Northwestern establishes Alzheimer's research hub with $25M gift
Work there will focus on creating a suite of AI tools, data sets and analysis methods that allow neuroscientists to ...
ScienceAlert on MSN5d
Alzheimer's Disease Harms The Brain in 2 Distinct Phases, Study Reveals
An analysis of the genetic activity of brain cells in individuals who have died with Alzheimer's disease has revealed the ...
Psychology Today3d
Early Signs of Alzheimer’s Disease? Follow the Money
As our family members age, we worry. We worry about their physical health and potential cognitive declines. If you are ...
WWLP Springfield on MSN4d
Walk to End Alzheimer’s in Holyoke to raise funds to end disease
The Alzheimer's Association Massachusetts-New Hampshire Chapter is fighting the disease at the Pioneer Valley Walk to End ...
FierceBiotech4h
Eisai, Eli Lilly didn’t disclose heightened brain injury risk to Alzheimer’s trial patients: NYT
A new bombshell has been dropped in the scandal-plagued world of Alzheimer’s disease drug development. | Between the two ...